Latest Orexo News & Updates

See the latest news and media coverage for Orexo. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Orexo

Pharmaceutical company developing treatments for opioid dependence and anaphylaxis

orexo.se
Headquarters
Fyrislund, Sweden
Founded year
1995
Company type
Public company
Number of employees
80–200

Last updated

Latest news about Orexo

In short: Orexo divested the U.S. rights for Zubsolv to Dexcel Pharma for $91 million, redeemed its social bonds early, and advanced its AmorphOX pipeline.

Company announcements

Orexo

Orexo calls for early bond redemption

It notifies holders of the senior secured social bonds 2024/2028 of the planned early redemption and provides investor relations contact details.

Orexo

Orexo changes its organizational structure and management team

The company aims to increase focus on developing new products.

Unlock all announcements with a

Media coverage

Dagens industri

Orexo reports redder figures

The specialist pharmaceutical company Orexo reports a net result of -134 million kronor (-15.9) for the first quarter of 2026. The result per...

Unlock all articles with a

Never miss news about Orexo

Track Orexo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Orexo competitors & trending companies

Browse news for competitors to Orexo and other trending companies.